The current financial score of AxoGen Inc is 7.59. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 69.73M, representing a year-over-year increase of 23.06%, while its net profit experienced a year-over-year increase of 361.83%.
The current valuation score of AxoGen Inc is 8.24. Its current P/E ratio is -68.14, which is -90.26% below the recent high of -6.64 and -1141.63% above the recent low of -846.01.
The current earnings forecast score of AxoGen Inc is 8.44. The average price target is 53.90, with a high of 60.00 and a low of 48.00.
The current price momentum score of AxoGen Inc is 4.65. Currently, the stock price is trading between the resistance level at 50.95 and the support level at 37.66, making it suitable for range-bound swing trading.
The current institutional shareholding score of AxoGen Inc is 10.00. The latest institutional shareholding proportion is 91.60%, representing a quarter-over-quarter decrease of 6.40%.
The current risk assessment score of AxoGen Inc is 6.37. The company's beta value is 1.14. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.